Professor Sara Mangsbo is a leading researcher and Professor of Protein and Antibody Drugs at Uppsala University, where she is renowned for her expertise in immunotherapy and precision medicine. With close to 15 years of experience, her work centers on developing antibody-based therapies that leverage the immune system’s natural mechanisms to combat cancer. A key focus of her research is on creating innovative treatments that target the CD40 protein, an essential player in activating immune responses specifically directed against cancer cells.

Committed to advancing personalized medicine, Professor Mangsbo aims to make these therapies both highly effective and accessible. Her research emphasizes not only enhancing treatment precision but also improving safety and adaptability, particularly through methods that can be tailored to individual patients’ unique cancer profiles.